X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1449) 1449
Book Review (241) 241
Publication (105) 105
Conference Proceeding (16) 16
Book Chapter (10) 10
Dissertation (4) 4
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1166) 1166
humans (974) 974
neoplasm recurrence, local - drug therapy (734) 734
female (679) 679
male (509) 509
middle aged (505) 505
oncology (499) 499
adult (438) 438
aged (433) 433
local drug delivery (399) 399
chemotherapy (346) 346
cancer (311) 311
animals (288) 288
treatment outcome (271) 271
drug delivery systems (230) 230
local-drug delivery (225) 225
neoplasm recurrence, local - pathology (213) 213
antineoplastic combined chemotherapy protocols - therapeutic use (210) 210
pharmacology & pharmacy (181) 181
care and treatment (178) 178
medicine & public health (168) 168
therapy (153) 153
paclitaxel (144) 144
surgery (140) 140
brain neoplasms - drug therapy (139) 139
combined modality therapy (136) 136
survival rate (136) 136
antineoplastic agents - therapeutic use (133) 133
restenosis (132) 132
prognosis (131) 131
drugs (128) 128
aged, 80 and over (126) 126
analysis (124) 124
neoplasm staging (123) 123
disease-free survival (122) 122
follow-up studies (122) 122
research (120) 120
radiotherapy (116) 116
retrospective studies (106) 106
vehicles (105) 105
neoplasm recurrence, local - radiotherapy (104) 104
antineoplastic agents - administration & dosage (101) 101
dentistry (101) 101
hematology, oncology and palliative medicine (101) 101
survival (100) 100
ovarian neoplasms - drug therapy (99) 99
cisplatin (97) 97
neoplasm recurrence, local - mortality (96) 96
cardiac & cardiovascular systems (94) 94
health aspects (92) 92
paclitaxel - administration & dosage (92) 92
tumors (92) 92
clinical neurology (90) 90
neoplasm recurrence, local - surgery (90) 90
carcinoma (88) 88
drug therapy (87) 87
clinical trials (86) 86
angioplasty (80) 80
periodontitis (79) 79
prospective studies (79) 79
trial (79) 79
antineoplastic combined chemotherapy protocols - adverse effects (78) 78
glioblastoma - drug therapy (78) 78
in-vitro (78) 78
obstetrics & gynecology (77) 77
survival analysis (77) 77
radiology, nuclear medicine & medical imaging (75) 75
ovarian cancer (74) 74
article (72) 72
dentistry, oral surgery & medicine (70) 70
metastasis (70) 70
bevacizumab (69) 69
dose-response relationship, drug (69) 69
glioma - drug therapy (69) 69
in-vivo (69) 69
antineoplastic agents (68) 68
cisplatin - administration & dosage (68) 68
drug administration schedule (67) 67
phase-ii (67) 67
antimitotic agents (66) 66
diseases (66) 66
materials science, biomaterials (64) 64
relapse (64) 64
carcinoma, squamous cell - drug therapy (63) 63
engineering, biomedical (63) 63
radiation-therapy (63) 63
adolescent (62) 62
antineoplastic agents - adverse effects (62) 62
stents (62) 62
antineoplastic combined chemotherapy protocols - administration & dosage (61) 61
toxicity (61) 61
glioblastoma (60) 60
chemistry, multidisciplinary (58) 58
disease (57) 57
drug delivery (57) 57
phase-ii trial (57) 57
magnetic resonance imaging (56) 56
mice (56) 56
nanoparticles (56) 56
oncology, experimental (56) 56
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1412) 1412
Japanese (22) 22
German (21) 21
Chinese (9) 9
French (4) 4
Korean (3) 3
Polish (2) 2
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Controlled Release, ISSN 0168-3659, 08/2017, Volume 259, pp. 128 - 135
Microbubbles (MB) are routinely used as contrast agents for ultrasound (US) imaging. We describe different types of targeted and drug-loaded poly( -butyl... 
Microbubbles | Tumor targeting | Ultrasound | Nanomedicine | Sonoporation | FOCUSED ULTRASOUND | LOADED MICROBUBBLES | ADHESION MOLECULES | TUMORS | CHEMISTRY, MULTIDISCIPLINARY | HEPATOCELLULAR-CARCINOMA | THERAPY | INFLAMMATION | E-SELECTIN | LOCAL-DRUG | PHARMACOLOGY & PHARMACY | BRAIN | Carotid Arteries - metabolism | Neoplasms - metabolism | Rhodamines - administration & dosage | Antibodies - chemistry | Humans | Neovascularization, Pathologic | Dextrans - chemistry | Male | Molecular Imaging | Vascular Endothelial Growth Factor Receptor-2 - immunology | Drug Delivery Systems | Biotin - chemistry | Brain - metabolism | Fluorescein-5-isothiocyanate - chemistry | Ultrasonography | Streptavidin - administration & dosage | Rhodamines - chemistry | Fluorescent Dyes - administration & dosage | Biotin - administration & dosage | Enbucrilate - administration & dosage | Streptavidin - chemistry | Ultrasonic Waves | Fluorescent Dyes - chemistry | Vascular Cell Adhesion Molecule-1 - immunology | Fluorescein-5-isothiocyanate - administration & dosage | Fluorescein-5-isothiocyanate - analogs & derivatives | E-Selectin - immunology | Neoplasms - diagnostic imaging | Enbucrilate - chemistry | Antibodies - administration & dosage | Animals | Carotid Arteries - diagnostic imaging | Mice, Nude | Cell Line, Tumor | Neoplasms - pathology | Dextrans - administration & dosage | Drugs | Drug delivery systems | Vehicles | Nitriles | Usage | Biomedical engineering | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 11/2013, Volume 171, Issue 3, pp. 280 - 287
Expression of the membrane protein CD133 marks a subset of cancer cells with drug resistant phenotype and enhanced tumor initiating ability in... 
Sustained release | Polymeric nanoparticles | Cancer stem cells | Targeted delivery | Cancer initiating cells | DRUG | PROSPECTIVE IDENTIFICATION | SENSITIVITY | CHEMISTRY, MULTIDISCIPLINARY | NANOPARTICLES | RESISTANCE | SURFACE | STEM-CELL | PHARMACOLOGY & PHARMACY | CD133(+) CELLS | IN-VITRO PROPAGATION | HEMATOPOIETIC STEM | Antibodies, Immobilized - chemistry | Antigens, CD - immunology | Antibodies, Immobilized - immunology | Nanoparticles - chemistry | Breast Neoplasms - immunology | Humans | Neoplasm Recurrence, Local - drug therapy | Paclitaxel - pharmacokinetics | Drug Carriers - chemistry | Drug Delivery Systems | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Antineoplastic Agents, Phytogenic - administration & dosage | Female | Antineoplastic Agents, Phytogenic - therapeutic use | Paclitaxel - administration & dosage | Antineoplastic Agents, Phytogenic - pharmacokinetics | Breast - pathology | Caco-2 Cells | Breast - immunology | Peptides - immunology | AC133 Antigen | Breast Neoplasms - drug therapy | Paclitaxel - therapeutic use | Glycoproteins - immunology | Animals | Breast - drug effects | Breast Neoplasms - pathology | Cell Line, Tumor | Mice | Mice, Inbred BALB C | Antimitotic agents | Care and treatment | Analysis | Monoclonal antibodies | Breast cancer | Drug resistance | Antineoplastic agents | Cancer | Index Medicus | Animal models
Journal Article
ACS Nano, ISSN 1936-0851, 07/2018, Volume 12, Issue 7, pp. 6685 - 6699
Journal Article
Journal Article